Calprotectin and Calgranulin C as Biomarkers of Pancreatic Tumors: Baseline Levels and Level Changes after Surgery

Table 2

Baseline characteristics of patients with malignant and benign tumors and healthy controls and their comparisons.

	Healthy controls ()	Patients with malignant tumors ()	Patients with benign tumors ()
Gender (M/F)	15/11	37/47	7/7
Mean age (years)	50.9	62.9	50.9	<0.05
Calprotectin (ng/mL)	847 (510-1349)	2650 (1885-4233)	4914 (3486-5478)	<0.05
Calgranulin C (ng/mL)	12.3 (6.0-16.9)	42.6 (25.0-64.3)	54.7 (46.2-120.3)	N.s.

: difference between cohorts with benign and malignant tumors; M: male; F: female; N.s.: not significant. and .